COVID-19: Vaccine | Testing | Self-assessment | Patient & Visitor Safety | Visitor Policy
Home > Clinical Trials > Clinical Trial Details
Back to Results
Request Additional Trial InformationFull Trial Details: ClinicalTrials.gov
Condition: Lung CancerStudy Type: InterventionalPhase: IIIStudy Start Date: 09/06/2018Study Completion Date: 09/2025
The primary purpose of the study is to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II -IIIA and the subset of IIIB (T>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.